A small clinical trial enrolling 24 patients with severe CRSwNP (NPS ≥5) who had already undergone nasal surgery, showed that a benralizumab 30-mg single dose improved NPS more than the placebo, although this did not reach statistical significance [ 88 ].
← all excerpts
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.
1
—
—